Millan, Mark J <br/><br/>
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Jun 2004 
 - 921-35 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.103.062414  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcholine--metabolism<br/>Animals<br/>Callithrix<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Dopamine Agonists--pharmacology<br/>Dopamine Antagonists--pharmacology<br/>Drug Interactions<br/>Dyskinesias--drug therapy<br/>Electrophysiology<br/>Extracellular Space<br/>Humans<br/>Hypokinesia--chemically induced<br/>Indoles--therapeutic use<br/>Levodopa--pharmacology<br/>MPTP Poisoning--drug therapy<br/>Male<br/>Motor Activity--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Oxazines--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Receptors, Dopamine D2--agonists<br/>Receptors, Dopamine D3<br/>Reserpine--pharmacology<br/>Rotation